US$ 27.61
glp-1 drugs and menopause GLP-1s, Obesity, Menopause: Benefits and Risks GLP-1 Medications and Their Role
Description
Tirzepatide was groundbreaking as the first dual GIP/GLP-1 receptor agonist, but it is no longer the only advanced option available

Accessed July 24, 2024

P., Bartchewsky, W

She was drawn to research on the molecule because of its potential to help treat type 2 diabetes
These combinations are largely untested in clinical trials

Insulin secretion deficits in a Prader-Willi syndrome -cell model are associated with a concerted downregulation of multiple endoplasmic reticulum chaperones